|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Deferred offering costs | ||||||||
| Current assets | ||||||||
| Cash | ||||||||
| Due from Sponsor | ||||||||
| Prepaid expenses | ||||||||
| Total Current Assets | ||||||||
| Investments held in Trust Account | ||||||||
| TOTAL ASSETS | ||||||||
| LIABILITIES AND SHAREHOLDERS' DEFICIT | ||||||||
| Current liabilities—accounts payable and accrued expenses | ||||||||
| Promissory note — related party | ||||||||
| Derivative warrant liabilities | ||||||||
| Deferred underwriting fee payable | ||||||||
| Total Liabilities | ||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value, 40,000,000 shares issued and outstanding at $10.01 and $10.00 per share redemption value as of June 30, 2022 and December 31, 2021, respectively | ||||||||
| Common Class A | ||||||||
| Total class A ordinary shares subject to possible redemption, $0.0001 par value, 40,000,000 shares issued and outstanding at $10.01 and $10.00 per share redemption value as of June 30, 2022 and December 31, 2021, respectively | ||||||||
| Shareholders' Deficit | ||||||||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued or outstanding | ||||||||
| Common stock value | ||||||||
| Common Class A | ||||||||
| Common Class B | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Common Class A | ||||||||
| Common Class B | ||||||||
| Total Shareholders' Deficit | ||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT |
Loading...
